Skip to content
Search

Latest Stories

RPS calls for increased Covid-19 protection for pharmacy teams

The Royal Pharmaceutical Society has joined over 20 other professional bodies and health organisations in demanding that the government and NHS increase Covid-19 protections for healthcare workers including community pharmacy teams.

In a meeting with government, NHS and public health officials on Thursday (June 3), the alliance of these organisations called for the UK infection prevention control guidance to be updated as well as making necessary arrangement for the supply of enhanced PPE for frontline healthcare workers.


“Whilst welcoming the government’s offer of further discussions, the alliance was disappointed that the UK guidance would not be updated at this time, despite emerging evidence and changes to guidance in the US and Europe,” the RPS said, sharing its concern over the safety of community pharmacy teams.

RPS president Sandra Gidley commented: “Supporting pharmacy teams and calling for appropriate PPE has been a key focus for the RPS during the pandemic.

“With frontline health and care staff under continued strain, we owe it to everybody to make sure they get the protection they deserve.

“As our understanding of Covid-19 evolves it’s vital that national guidance and support keep pace.”

The alliance believes that changes to the guidance are essential and should not be delayed. New Covid-19 variants and recent rises in positive cases make the case urgent for healthcare workers to be fully protected and provided with FFP3 masks when seeing patients, the RPS stressed.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less